A Phase 1b/2a Two-Part Open-Label Multicentre Study to Evaluate the Safety and Efficacy of LY2880070 as Monotherapy and in Combination With Gemcitabine in Patients With Advanced or Metastatic Cancer
The main purpose of this two-part study is to evaluate the safety and efficacy of the study
drug known as LY2880070 in participants with advanced or metastatic solid tumours.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society